# Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)

> **NCT06681038** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 114 (estimated)

## Conditions studied

- Peritoneal Metastases from Colorectal Cancer

## Interventions

- **DRUG:** Standard Medical Therapy
- **PROCEDURE:** PIPAC

## Key facts

- **NCT ID:** NCT06681038
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2029-08
- **Final completion:** 2029-08
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681038, "Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06681038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*